Clinical Trial Update: Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 open-label trial of bendamustine hydrochloride in women with advanced ovarian cancer. The study has completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Bendamustine Hydrochloride (bendamustine)

Snippet

Sponsor: University of Arizona | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-11-29